Clinical Validation of Next-Generation DNA Sequencing for Early Neoplastic Risk Assessment of Cystic Pancreatic Lesions: Ultra-Sensitive SafeSeq Molecular Barcoding Technique-MedSci.cn

Clinical Validation of Next-Generation DNA Sequencing for Early Neoplastic Risk Assessment of Cystic Pancreatic Lesions: Ultra-Sensitive SafeSeq Molecular Barcoding Technique

Parimi, V; Adams, E; Pallavajjala, A; Huang, JL; Xian, RN; Gocke, C; Lin, MT; Vogelstein, B; Eshleman, J

MODERN PATHOLOGY, 2021; 34 (SUPPL 2): 1054